83
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
371891
Cambridge Molecular is a biotechnology company that uses novel algorithms and cloud computing to accelerate drug discovery.
- Dmitry Foxham: Founder
- Guy Lewy: Chief Executive Officer
About the Company
Cambridge Molecular operates in the biotechnology industry, focusing on the acceleration and risk reduction of drug discovery. The company utilizes novel algorithms and high-performance cloud computing to enhance its operations. One of its key offerings is the suite of DEL data-powered virtual screening systems. Additionally, Cambridge Molecular
has developed a deep learning DEL follow-up tool, DeepDELve 2, which is applied to a vast catalogue of small molecules. The company also offers a system called PocketMapper and has a pipeline for automated extraction of chemical property information from scientific documents.
